Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Orthofix Medical Inc., 3 years.
Orthofix Medical Inc.
Director
RxSight Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
RxSight Inc. June 16, 2026100.0%
-
Orthofix Medical Inc. June 11, 202698.6%
-
Orthofix Medical Inc. June 18, 202599.1%
-
Orthofix Medical Inc. June 18, 202498.2%
-
Orthofix Medical Inc. June 19, 202399.1%
-
RxSight Inc. June 1, 202390.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | RxSight Inc. | Grant or award | +37,037 | — | — |
| Jun 10, 2026 | Orthofix Medical Inc. | Grant or award | +14,965 | — | — |
| Jun 18, 2025 | Orthofix Medical Inc. | Grant or award | +18,841 | — | — |
| Jun 3, 2025 | RxSight Inc. | Grant or award | +10,752 | — | — |
| Jan 22, 2025 | RxSight Inc. | Open-market sale | −3,519 | $30.87 | $108,632 |
| Nov 26, 2024 | RxSight Inc. | Open-market sale | −3,782 | $45.88 | $173,518 |
| Jun 18, 2024 | Orthofix Medical Inc. | Grant or award | +15,152 | $12.87 | $195,006 |
| Jun 6, 2024 | RxSight Inc. | Grant or award | +2,554 | — | — |
| Jan 18, 2024 | RxSight Inc. | Open-market sale | −3,520 | $45.69 | $160,829 |
| Jan 18, 2024 | RxSight Inc. | Open-market sale | −2,879 | $45.76 | $131,743 |
| Jan 8, 2024 | RxSight Inc. | Open-market sale | −6,418 | $45.00 | $288,810 |
| Aug 29, 2023 | RxSight Inc. | Open-market sale | −4,292 | $28.06 | $120,434 |
| Jun 1, 2023 | RxSight Inc. | Grant or award | +5,731 | — | — |
| Mar 10, 2023 | Orthofix Medical Inc. | Open-market sale | −4,262 | $17.75 | $75,651 |
| Jan 5, 2023 | Orthofix Medical Inc. | Grant or award | +14,052 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.